Nan Fung Group Holdings as of Sept. 30, 2021
Portfolio Holdings for Nan Fung Group Holdings
Nan Fung Group Holdings holds 28 positions in its portfolio as reported in the September 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| New Frontier Health Corp Ord Shs | 30.0 | $94M | 8.4M | 11.23 | |
| Illumina (ILMN) | 16.8 | $53M | 130k | 405.61 | |
| Harmony Biosciences Hldgs In (HRMY) | 9.4 | $30M | 769k | 38.33 | |
| Karuna Therapeutics Ord | 9.2 | $29M | 235k | 122.33 | |
| Somalogic Class A Com | 6.7 | $21M | 1.7M | 12.39 | |
| Eargo | 6.2 | $19M | 2.9M | 6.73 | |
| Bolt Biotherapeutics (BOLT) | 4.7 | $15M | 1.2M | 12.65 | |
| Rani Therapeutics Hldgs Com Cl A (RANI) | 2.8 | $8.8M | 494k | 17.82 | |
| Vir Biotechnology (VIR) | 2.2 | $7.0M | 160k | 43.52 | |
| Galera Therapeutics (GRTX) | 1.6 | $5.0M | 613k | 8.10 | |
| Beam Therapeutics (BEAM) | 1.5 | $4.8M | 55k | 87.01 | |
| New Frontier Health Corp *w Exp 11/30/202 | 1.4 | $4.5M | 1.6M | 2.82 | |
| Invitae (NVTAQ) | 1.3 | $4.1M | 145k | 28.43 | |
| Alx Oncology Hldgs (ALXO) | 1.0 | $3.1M | 42k | 73.85 | |
| Xenon Pharmaceuticals (XENE) | 1.0 | $3.0M | 198k | 15.28 | |
| Dbv Technologies S A Sponsored Adr (DBVT) | 0.6 | $1.8M | 371k | 4.90 | |
| EXACT Sciences Corporation (EXAS) | 0.5 | $1.7M | 18k | 95.45 | |
| Otonomy | 0.5 | $1.6M | 851k | 1.92 | |
| Kalvista Pharmaceuticals (KALV) | 0.4 | $1.4M | 79k | 17.45 | |
| Exelixis (EXEL) | 0.4 | $1.4M | 64k | 21.14 | |
| Sierra Oncology Com New | 0.4 | $1.2M | 53k | 21.91 | |
| Rubius Therapeutics | 0.3 | $1.0M | 57k | 17.88 | |
| Reata Pharmaceuticals Cl A | 0.3 | $832k | 8.3k | 100.67 | |
| Satsuma Pharmaceuticals Ord | 0.2 | $666k | 143k | 4.66 | |
| Fluent Inc cs (FLNT) | 0.1 | $442k | 195k | 2.27 | |
| Synlogic | 0.1 | $209k | 69k | 3.05 | |
| Dyne Therapeutics (DYN) | 0.1 | $189k | 12k | 16.25 | |
| Akero Therapeutics (AKRO) | 0.0 | $78k | 3.5k | 22.48 |
